Categories


Profits over people

March 13, 2005 - Though it was taken off the market in September, it could be a while before the effects of the drug Vioxx have worn off. Read More


Drug Linked to Death of Jawbone

March 13, 2005 - Salvatore Ruggiero was puzzled. Over a three-year period, the jaws of dozens of patients who had undergone oral surgery at his hospital had failed to heal properly. Read More


More 3M Water Testing Urged

March 11, 2005 - State Health Department officials are testing wells near Cottage Grove for contamination by two 3M Co. chemicals, but a national environmental group is urging Minnesota's Pollution Control... Read More


FDA Issues Alert to Crestor Users

March 2, 2005 - Crestor is being revised to highlight important information on the safe use of Crestor to reduce the risk for serious muscle toxicity (myopathy/rhabdomyolysis), especially at the highest... Read More


A Vioxx Comeback Could Tilt Balance in Merck Litigation

February 22, 2005 - The possibility that Vioxx may once again be offered to patients raises a provocative question: Did Merck & Co. err by pulling its $2.5 billion painkiller off the market? Read More


Return of Vioxx would be unusual, not unprecedented

February 22, 2005 - If Merck puts painkiller Vioxx back on the market after removing it because of safety concerns, it would be an unusual but not unprecedented event. Read More


FDA panel supports return of Vioxx

February 21, 2005 - A Food and Drug Administration (news - web sites) panel's support for Vioxx, Celebrex and Bextra is good news for Merck and Pfizer, but restoring consumers' confidence in the three COX=2... Read More


New Orleans Judge to Preside over Vioxx Cases

February 16, 2005 - It was announced that cases involving claims arising out of the use of Vioxx will be transferred to the U.S. District Court for the Eastern District of Louisiana in New Orleans. Read More


Marketing of Vioxx how Merck played game of Catch Up

February 11, 2005 - At times, it is necessary to "neutralize" the opposition, or at least Merck & Company executives seemed to think so. Read More


Not every Player in the next Big Tort is Representing a Client.

February 1, 2005 - The Vioxx litigation has attracted big names from the mass tort bar. And, though he's not among plaintiffs counsel, per se, the lineup now includes Mr. Civil Action. That, of course, is Jan... Read More


back to top